Literature DB >> 24515303

HIV subtype is not associated with dementia among individuals with moderate and advanced immunosuppression in Kampala, Uganda.

Ned Sacktor1, Noeline Nakasujja, Andrew D Redd, Jordyn Manucci, Oliver Laeyendecker, Sarah K Wendel, Stephen F Porcella, Craig Martens, Daniel Bruno, Richard L Skolasky, Ozioma C Okonkwo, Kevin Robertson, Seggane Musisi, Elly Katabira, Thomas C Quinn.   

Abstract

HIV-associated neurocognitive disorders (HAND) are a common neurological manifestation of HIV infection. A previous study suggested that HIV dementia may be more common among patients with subtype D virus than among those with subtype A virus among HIV+ individuals with advanced immunosuppression. We conducted a study to evaluate the frequency of HIV dementia, and the association of HIV dementia with HIV subtype and compartmentalization among HIV+ individuals with moderate and advanced immunosuppression (CD4 lymphocyte count >150 cells/μL and <250 cells/μL). The study enrolled 117 antiretroviral naïve HIV+ individuals in Kampala, Uganda. HIV+ individuals received neurological, neuropsychological testing, and functional assessments, and gag and gp41 regions were subtyped. Subjects were considered infected with a specific subtype if both regions analyzed were from the same subtype. 41% of the HIV+ individuals had HIV dementia (mean CD4 lymphocyte count = 233 cells/μL). 67 individuals had subtype A, 25 individuals had subtype D, 24 individuals were classified as A/D recombinants, and one individual had subtype C. There was no difference in the frequency of HIV dementia when stratified by HIV subtype A and D and no association with compartmentalization between the cerebrospinal fluid and peripheral blood. These results suggest that HIV dementia is common in HIV+ individuals in Uganda. There was no association between HIV subtype and dementia among HIV+ individuals with moderate and advanced immunosuppression. Future studies should be performed to confirm these results.

Entities:  

Mesh:

Year:  2014        PMID: 24515303      PMCID: PMC4024330          DOI: 10.1007/s11011-014-9498-3

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  24 in total

1.  HIV-subtype A is associated with poorer neuropsychological performance compared with subtype D in antiretroviral therapy-naive Ugandan children.

Authors:  Michael J Boivin; Theodore D Ruel; Hannah E Boal; Paul Bangirana; Huyen Cao; Leigh A Eller; Edwin Charlebois; Diane V Havlir; Moses R Kamya; Jane Achan; Carolyne Akello; Joseph K Wong
Journal:  AIDS       Date:  2010-05-15       Impact factor: 4.177

2.  Changes in the distribution of HIV type 1 subtypes D and A in Rakai District, Uganda between 1994 and 2002.

Authors:  Samantha A Conroy; Oliver Laeyendecker; Andrew D Redd; Aleisha Collinson-Streng; Xiangrong Kong; Fredrick Makumbi; Tom Lutalo; Nelson Sewankambo; Noah Kiwanuka; Ronald H Gray; Maria J Wawer; David Serwadda; Thomas C Quinn
Journal:  AIDS Res Hum Retroviruses       Date:  2010-10-06       Impact factor: 2.205

3.  Detection of diverse variants of human immunodeficiency virus-1 groups M, N, and O and simian immunodeficiency viruses from chimpanzees by using generic pol and env primer pairs.

Authors:  C Yang; B C Dash; F Simon; G van der Groen; D Pieniazek; F Gao; B H Hahn; R B Lal
Journal:  J Infect Dis       Date:  2000-05-15       Impact factor: 5.226

4.  Identification of HIV superinfection in seroconcordant couples in Rakai, Uganda, by use of next-generation deep sequencing.

Authors:  Andrew D Redd; Aleisha Collinson-Streng; Craig Martens; Stacy Ricklefs; Caroline E Mullis; Jordyn Manucci; Aaron A R Tobian; Ethan J Selig; Oliver Laeyendecker; Nelson Sewankambo; Ronald H Gray; David Serwadda; Maria J Wawer; Stephen F Porcella; Thomas C Quinn
Journal:  J Clin Microbiol       Date:  2011-06-22       Impact factor: 5.948

5.  HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads.

Authors:  Jared M Baeten; Bhavna Chohan; Ludo Lavreys; Vrasha Chohan; R Scott McClelland; Laura Certain; Kishorchandra Mandaliya; Walter Jaoko; Julie Overbaugh
Journal:  J Infect Dis       Date:  2007-03-02       Impact factor: 5.226

6.  Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa.

Authors:  N Sacktor; N Nakasujja; R Skolasky; K Robertson; M Wong; S Musisi; A Ronald; E Katabira
Journal:  Neurology       Date:  2006-07-25       Impact factor: 9.910

7.  The International HIV Dementia Scale: a new rapid screening test for HIV dementia.

Authors:  Ned C Sacktor; Matthew Wong; Noeline Nakasujja; Richard L Skolasky; Ola A Selnes; Seggane Musisi; Kevin Robertson; Justin C McArthur; Allan Ronald; Elly Katabira
Journal:  AIDS       Date:  2005-09-02       Impact factor: 4.177

8.  WHO Neuropsychiatric AIDS study, cross-sectional phase II. Neuropsychological and neurological findings.

Authors:  M Maj; P Satz; R Janssen; M Zaudig; F Starace; L D'Elia; B Sughondhabirom; M Mussa; D Naber; D Ndetei
Journal:  Arch Gen Psychiatry       Date:  1994-01

9.  Predicted HIV-1 coreceptor usage among Kenya patients shows a high tendency for subtype d to be cxcr4 tropic.

Authors:  Veronica Wambui; Michael Kiptoo; Joyceline Kinyua; Irene Odera; Edward Muge; Peter Muiruri; Raphael Lihana; Peter Kinyanjui; Elijah M Songok
Journal:  AIDS Res Ther       Date:  2012-07-28       Impact factor: 2.250

10.  Pattern of neuropsychological performance among HIV positive patients in Uganda.

Authors:  Kevin R Robertson; Noeline Nakasujja; Matthew Wong; Seggane Musisi; Elly Katabira; Thomas D Parsons; Allan Ronald; Ned Sacktor
Journal:  BMC Neurol       Date:  2007-04-05       Impact factor: 2.474

View more
  10 in total

1.  Suicide risk and prevalence of major depressive disorder (MDD) among individuals infected with HIV-1 subtype C versus B in Southern Brazil.

Authors:  Sergio Monteiro de Almeida; Francisco Jaime Barbosa; Rujvi Kamat; Ana Paula de Pereira; Sonia Mara Raboni; Indianara Rotta; Clea Elisa Ribeiro; Mariana Cherner; Ronald J Ellis; Joseph Hampton Atkinson
Journal:  J Neurovirol       Date:  2016-07-18       Impact factor: 2.643

2.  Prevalence and Risk Factors of HIV-Associated Neurocognitive Disorders in Rural Southwestern Uganda.

Authors:  Jane Kasozi Namagga; Godfrey Zari Rukundo; Joachim G Voss
Journal:  J Assoc Nurses AIDS Care       Date:  2019 Sep-Oct       Impact factor: 1.354

3.  Assessment of neurocognitive deficits in people living with HIV in Sub Saharan Africa: A systematic review.

Authors:  Primrose Nyamayaro; Dixon Chibanda; Reuben N Robbins; James Hakim; Hetta Gouse
Journal:  Clin Neuropsychol       Date:  2019-05-01       Impact factor: 3.535

4.  Neuroimaging abnormalities in clade C HIV are independent of Tat genetic diversity.

Authors:  Robert H Paul; Sarah Phillips; Jacqueline Hoare; David H Laidlaw; Ryan Cabeen; Gayla R Olbricht; Yuqing Su; Dan J Stein; Susan Engelbrecht; Soraya Seedat; Lauren E Salminen; Laurie M Baker; Jodi Heaps; John Joska
Journal:  J Neurovirol       Date:  2016-12-02       Impact factor: 2.643

5.  Effect of HIV Subtype and Antiretroviral Therapy on HIV-Associated Neurocognitive Disorder Stage in Rakai, Uganda.

Authors:  Ned Sacktor; Deanna Saylor; Gertrude Nakigozi; Noeline Nakasujja; Kevin Robertson; M Kate Grabowski; Alice Kisakye; James Batte; Richard Mayanja; Aggrey Anok; Ronald H Gray; Maria J Wawer
Journal:  J Acquir Immune Defic Syndr       Date:  2019-06-01       Impact factor: 3.731

6.  Neruodevelopmental Outcomes in Preschool Children Living With HIV-1 Subtypes A and D in Uganda.

Authors:  Horacio Ruiseñor-Escudero; Alla Sikorskii; Itziar Familiar-Lopez; Deborah Persaud; Carrie Ziemniak; Noeline Nakasujja; Robert Opoka; Michael Boivin
Journal:  Pediatr Infect Dis J       Date:  2018-12       Impact factor: 2.129

7.  Cerebrospinal fluid can be used for HIV genotyping when it fails in blood.

Authors:  Indianara Rotta; Sonia Mara Raboni; Cléa Elisa Lopes Ribeiro; Maristela Riedel; Maria da Graça Winhescki; Davey M Smith; Ronald J Ellis; Sérgio Monteiro de Almeida
Journal:  Arq Neuropsiquiatr       Date:  2014-07       Impact factor: 1.420

Review 8.  Neurological disorders in HIV in Africa: a review.

Authors:  William P Howlett
Journal:  Afr Health Sci       Date:  2019-06       Impact factor: 0.927

9.  Absence of neurocognitive disadvantage associated with paediatric HIV subtype A infection in children on antiretroviral therapy.

Authors:  Paul Bangirana; Theodore D Ruel; Michael J Boivin; Satish K Pillai; Leila B Giron; Alla Sikorskii; Asish Banik; Jane Achan
Journal:  J Int AIDS Soc       Date:  2017-10       Impact factor: 5.396

10.  Prevalence of Severe Neurocognitive Impairment and Its Association with Socio-Demographics and Functionality Among Ugandan Older Persons: A Hospital-Based Study.

Authors:  Letizia Maria Atim; Mark Mohan Kaggwa; Mohammed A Mamun; Scholastic Ashaba; Samuel Maling
Journal:  Clin Interv Aging       Date:  2021-07-22       Impact factor: 4.458

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.